84 FR 75 pgs. 16220-16222 - Sunscreen Drug Products for Over-the-Counter Human Use; Correction
Type: PRORULEVolume: 84Number: 75Pages: 16220 - 16222
Pages: 16220, 16221, 16222Docket number: [Docket No. FDA-1978-N-0018 (formerly Docket No. FDA-1978-N-0038)]
FR document: [FR Doc. 2019-07712 Filed 4-17-19; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 201
[Docket No. FDA-1978-N-0018 (formerly Docket No. FDA-1978-N-0038)]
RIN 0910-AF43
Sunscreen Drug Products for Over-the-Counter Human Use; Correction
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Proposed rule; correction.
SUMMARY:
The Food and Drug Administration (FDA) is correcting a proposed rule relating to the regulation of over-the-counter (OTC) sunscreen monograph products that appeared in the Federal Register of February 26, 2019. The document was published with formulas that were illegible. These corrections are being made to improve the accuracy of the proposed rule.
DATES:
Submit either electronic or written comments on the proposed rule by June 27, 2019.
FOR FURTHER INFORMATION CONTACT:
Kristen Hardin, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, Rm. 5443, Silver Spring, MD 20993, 240-402-4246.
SUPPLEMENTARY INFORMATION:
In the Federal Register of February 26, 2019 (84 FR 6204), in FR Doc. 2019-03019, on pages 6267 through 6270, the following corrections are made:
1. On page 6267, in the first column, the formula under §?201.327(i)(2)(ii)(B) is corrected to read:
BILLING CODE 4164-01-P
[Federal Register graphic "EP18AP19.004" is not available. Please view the graphic in the PDF version of this document.]
[top]
2. On page 6268, in the second column, the formula under §?201.327(i)(3)(ii)(C)( 2 ) is corrected to read:
[Federal Register graphic "EP18AP19.005" is not available. Please view the graphic in the PDF version of this document.]
3. On page 6268, in the second column, the formulas under §?201.327(i)(3)(ii)(D)( 2 )( i ) are corrected to read:
[Federal Register graphic "EP18AP19.006" is not available. Please view the graphic in the PDF version of this document.]
4. On page 6269, in the third column, the formula under §?201.327(i)(7)(i) is corrected to read:
[Federal Register graphic "EP18AP19.007" is not available. Please view the graphic in the PDF version of this document.]
5. On page 6269, in the third column, the formulas under §?201.327(i)(7)(ii) are corrected to read:
[Federal Register graphic "EP18AP19.008" is not available. Please view the graphic in the PDF version of this document.]
6. On page 6270, in the second column, the formula under §?201.327(j)(4)(ii) is corrected to read:
[Federal Register graphic "EP18AP19.009" is not available. Please view the graphic in the PDF version of this document.]
7. On page 6270, in the third column, the formulas under §?201.327(j)(5)(i) are corrected to read:
[top]
[Federal Register graphic "EP18AP19.010" is not available. Please view the graphic in the PDF version of this document.]
8. On page 6270, in the third column, the formula under §?201.327(j)(7) is corrected to read:
[Federal Register graphic "EP18AP19.011" is not available. Please view the graphic in the PDF version of this document.]
9. On page 6270, in the third column, the formula under §?201.327(j)(8) is corrected to read:
[Federal Register graphic "EP18AP19.012" is not available. Please view the graphic in the PDF version of this document.]
Elsewhere in this issue of the Federal Register , FDA is extending the comment period on the proposed rule.
Dated: April 12, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019-07712 Filed 4-17-19; 8:45 am]
BILLING CODE 4164-01-C